Annual EBITDA
-$94.31 M
-$19.72 M-26.44%
December 31, 2024
Summary
- As of March 13, 2025, AVBP annual EBITDA is -$94.31 million, with the most recent change of -$19.72 million (-26.44%) on December 31, 2024.
- AVBP annual EBITDA is now -155.54% below its all-time high of -$36.91 million, reached on December 31, 2022.
Performance
AVBP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$23.70 M
+$527.00 K+2.17%
December 31, 2024
Summary
- As of March 13, 2025, AVBP quarterly EBITDA is -$23.70 million, with the most recent change of +$527.00 thousand (+2.17%) on December 31, 2024.
- Over the past year, AVBP quarterly EBITDA has increased by +$1.99 million (+7.75%).
- AVBP quarterly EBITDA is now -127.02% below its all-time high of -$10.44 million, reached on December 1, 2022.
Performance
AVBP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$94.31 M
-$587.00 K-0.63%
December 31, 2024
Summary
- As of March 13, 2025, AVBP TTM EBITDA is -$94.31 million, with the most recent change of -$587.00 thousand (-0.63%) on December 31, 2024.
- Over the past year, AVBP TTM EBITDA has dropped by -$8.10 million (-9.40%).
- AVBP TTM EBITDA is now -701.39% below its all-time high of -$11.77 million, reached on September 1, 2022.
Performance
AVBP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVBP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.4% | +7.8% | -9.4% |
| 3 y3 years | - | +7.8% | -9.4% |
| 5 y5 years | - | +7.8% | -9.4% |
AVBP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -155.5% | at low | -127.0% | +7.8% | -701.4% | at low |
| 5 y | 5-year | -155.5% | at low | -127.0% | +7.8% | -701.4% | at low |
| alltime | all time | -155.5% | at low | -127.0% | +7.8% | -701.4% | at low |
ArriVent BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$94.31 M(+26.4%) | -$23.70 M(-2.2%) | -$94.31 M(+0.6%) |
| Sep 2024 | - | -$24.23 M(-5.7%) | -$93.72 M(+8.7%) |
| Jun 2024 | - | -$25.70 M(+24.3%) | -$86.20 M(+3.7%) |
| Mar 2024 | - | -$20.67 M(-10.6%) | -$83.09 M(+11.4%) |
| Dec 2023 | -$74.59 M | -$23.12 M(+38.3%) | -$74.59 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$16.72 M(-26.0%) | -$61.91 M(+8.7%) |
| Jun 2023 | - | -$22.58 M(+85.5%) | -$56.97 M(+65.7%) |
| Mar 2023 | - | -$12.17 M(+16.6%) | -$34.38 M(+54.8%) |
| Dec 2022 | -$36.91 M | - | - |
| Dec 2022 | - | -$10.44 M(-11.3%) | -$22.21 M(+88.7%) |
| Sep 2022 | - | -$11.77 M | -$11.77 M |
FAQ
- What is ArriVent BioPharma annual EBITDA?
- What is the all time high annual EBITDA for ArriVent BioPharma?
- What is ArriVent BioPharma annual EBITDA year-on-year change?
- What is ArriVent BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly EBITDA year-on-year change?
- What is ArriVent BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for ArriVent BioPharma?
- What is ArriVent BioPharma TTM EBITDA year-on-year change?
What is ArriVent BioPharma annual EBITDA?
The current annual EBITDA of AVBP is -$94.31 M
What is the all time high annual EBITDA for ArriVent BioPharma?
ArriVent BioPharma all-time high annual EBITDA is -$36.91 M
What is ArriVent BioPharma annual EBITDA year-on-year change?
Over the past year, AVBP annual EBITDA has changed by -$19.72 M (-26.44%)
What is ArriVent BioPharma quarterly EBITDA?
The current quarterly EBITDA of AVBP is -$23.70 M
What is the all time high quarterly EBITDA for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly EBITDA is -$10.44 M
What is ArriVent BioPharma quarterly EBITDA year-on-year change?
Over the past year, AVBP quarterly EBITDA has changed by +$1.99 M (+7.75%)
What is ArriVent BioPharma TTM EBITDA?
The current TTM EBITDA of AVBP is -$94.31 M
What is the all time high TTM EBITDA for ArriVent BioPharma?
ArriVent BioPharma all-time high TTM EBITDA is -$11.77 M
What is ArriVent BioPharma TTM EBITDA year-on-year change?
Over the past year, AVBP TTM EBITDA has changed by -$8.10 M (-9.40%)